JP2021514674A5 - - Google Patents
Info
- Publication number
- JP2021514674A5 JP2021514674A5 JP2020568035A JP2020568035A JP2021514674A5 JP 2021514674 A5 JP2021514674 A5 JP 2021514674A5 JP 2020568035 A JP2020568035 A JP 2020568035A JP 2020568035 A JP2020568035 A JP 2020568035A JP 2021514674 A5 JP2021514674 A5 JP 2021514674A5
- Authority
- JP
- Japan
- Prior art keywords
- bont
- sequence
- polypeptide
- tab
- tba
- Prior art date
Links
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2024043984A JP2024069606A (ja) | 2018-02-26 | 2024-03-19 | ボツリヌス神経毒バイオハイブリッド |
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| SE1850213-8 | 2018-02-26 | ||
| SE1850213A SE542539C2 (en) | 2018-02-26 | 2018-02-26 | Chimeric botulinum neurotoxin heavy chain binding domain |
| PCT/EP2019/054310 WO2019162376A1 (en) | 2018-02-26 | 2019-02-21 | Botulinum neurotoxin biohybrid |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2024043984A Division JP2024069606A (ja) | 2018-02-26 | 2024-03-19 | ボツリヌス神経毒バイオハイブリッド |
Publications (4)
| Publication Number | Publication Date |
|---|---|
| JP2021514674A JP2021514674A (ja) | 2021-06-17 |
| JP2021514674A5 true JP2021514674A5 (https=) | 2022-03-03 |
| JPWO2019162376A5 JPWO2019162376A5 (https=) | 2022-03-03 |
| JP7458999B2 JP7458999B2 (ja) | 2024-04-01 |
Family
ID=65576340
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2020568035A Active JP7458999B2 (ja) | 2018-02-26 | 2019-02-21 | ボツリヌス神経毒バイオハイブリッド |
| JP2024043984A Withdrawn JP2024069606A (ja) | 2018-02-26 | 2024-03-19 | ボツリヌス神経毒バイオハイブリッド |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2024043984A Withdrawn JP2024069606A (ja) | 2018-02-26 | 2024-03-19 | ボツリヌス神経毒バイオハイブリッド |
Country Status (16)
| Country | Link |
|---|---|
| US (2) | US20200407702A1 (https=) |
| EP (1) | EP3759124A1 (https=) |
| JP (2) | JP7458999B2 (https=) |
| KR (1) | KR20200127175A (https=) |
| CN (1) | CN111819189A (https=) |
| AU (2) | AU2019223130B2 (https=) |
| BR (1) | BR112020017323A2 (https=) |
| CA (1) | CA3088928A1 (https=) |
| CL (1) | CL2020002186A1 (https=) |
| IL (1) | IL276930A (https=) |
| MX (1) | MX2020008834A (https=) |
| MY (1) | MY202690A (https=) |
| PH (1) | PH12020551270A1 (https=) |
| SE (1) | SE542539C2 (https=) |
| SG (1) | SG11202006730SA (https=) |
| WO (1) | WO2019162376A1 (https=) |
Families Citing this family (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP3752128B1 (de) * | 2018-02-16 | 2025-01-15 | preclinics discovery GmbH | Nukleinsäure-basiertes botulinum neurotoxin zur therapeutischen anwendung |
| IL272002A (en) | 2020-01-13 | 2021-07-29 | The Israel Institute Of Biological Res Iibr | Methods for identifying anti clostridial neurotoxin compounds |
| EP4093434A4 (en) * | 2020-01-21 | 2024-06-26 | Trustees of Dartmouth College | Immunologically optimized botulinum toxin light chain variants |
| CN111675754A (zh) * | 2020-05-19 | 2020-09-18 | 四川一埃科技有限公司 | 一种肉毒毒素蛋白晶体结构及晶体制备方法和解析方法 |
| CN114957482B (zh) * | 2021-02-26 | 2024-09-24 | 重庆誉颜制药有限公司 | 一种经修饰的神经毒素的单链多肽及其用途 |
Family Cites Families (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN102219837B (zh) * | 2010-05-20 | 2013-10-30 | 中国人民解放军军事医学科学院微生物流行病研究所 | 重组全长a型肉毒毒素突变体疫苗 |
| SG10201606666XA (en) * | 2012-05-30 | 2016-09-29 | Harvard College | Engineered Botulinum Neurotoxin |
| PT3274364T (pt) * | 2015-03-26 | 2021-11-05 | Harvard College | Neurotoxina botulínica manipulada |
| TW201718627A (zh) * | 2015-06-11 | 2017-06-01 | 梅茲製藥有限兩合公司 | 重組梭菌神經毒素及其使用與形成方法、包括其之醫藥組合物及對應其之前驅物、編碼前驅物之核酸序列及其獲得方法與前驅物之形成方法、載體與包括核酸序列之重組宿主細胞 |
| GB201607901D0 (en) * | 2016-05-05 | 2016-06-22 | Ipsen Biopharm Ltd | Chimeric neurotoxins |
| US11242515B2 (en) | 2016-05-16 | 2022-02-08 | President And Fellows Of Harvard College | Method for purification and activation of botulinum neurotoxin |
| CN109476713A (zh) | 2016-06-08 | 2019-03-15 | 儿童医学中心公司 | 工程改造的肉毒杆菌神经毒素 |
-
2018
- 2018-02-26 SE SE1850213A patent/SE542539C2/en not_active IP Right Cessation
-
2019
- 2019-02-21 SG SG11202006730SA patent/SG11202006730SA/en unknown
- 2019-02-21 US US16/975,308 patent/US20200407702A1/en not_active Abandoned
- 2019-02-21 MY MYPI2020003674A patent/MY202690A/en unknown
- 2019-02-21 EP EP19707750.6A patent/EP3759124A1/en active Pending
- 2019-02-21 CA CA3088928A patent/CA3088928A1/en active Pending
- 2019-02-21 BR BR112020017323-1A patent/BR112020017323A2/pt not_active IP Right Cessation
- 2019-02-21 MX MX2020008834A patent/MX2020008834A/es unknown
- 2019-02-21 AU AU2019223130A patent/AU2019223130B2/en not_active Expired - Fee Related
- 2019-02-21 CN CN201980015353.XA patent/CN111819189A/zh active Pending
- 2019-02-21 JP JP2020568035A patent/JP7458999B2/ja active Active
- 2019-02-21 KR KR1020207024402A patent/KR20200127175A/ko not_active Ceased
- 2019-02-21 WO PCT/EP2019/054310 patent/WO2019162376A1/en not_active Ceased
-
2020
- 2020-08-18 PH PH12020551270A patent/PH12020551270A1/en unknown
- 2020-08-25 IL IL276930A patent/IL276930A/en unknown
- 2020-08-25 CL CL2020002186A patent/CL2020002186A1/es unknown
-
2024
- 2024-03-19 JP JP2024043984A patent/JP2024069606A/ja not_active Withdrawn
- 2024-03-25 US US18/615,341 patent/US20250034540A1/en not_active Abandoned
- 2024-10-24 AU AU2024227611A patent/AU2024227611A1/en not_active Abandoned
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2021514674A5 (https=) | ||
| JP2019523015A5 (https=) | ||
| JP7434263B2 (ja) | 陽イオン性神経毒 | |
| JP2019216735A5 (https=) | ||
| JP2019528042A5 (https=) | ||
| JP2015519362A5 (https=) | ||
| US12478663B2 (en) | Use of botulinum neurotoxin in the treatment of sialorrhea | |
| JP2022046597A5 (https=) | ||
| ES2873479T3 (es) | Neurotoxinas catiónicas | |
| FI3481852T3 (fi) | Uusi botulinum-neurotoksiini ja sen johdannaisia | |
| RU2017134357A (ru) | Сконструированный ботулинический нейротоксин | |
| JP2015536654A5 (https=) | ||
| JP2019533430A5 (https=) | ||
| JP2016513082A5 (https=) | ||
| JP2015504304A (ja) | ポリ−グリシンを伴う修飾神経毒及びその使用 | |
| JP2025118631A (ja) | ボツリヌス神経毒素効果を調節する組成物 | |
| CN121534167A (zh) | 修饰的BoNT/A用于颈肌张力障碍的治疗 | |
| KR20210130711A (ko) | 진전의 치료를 위한 보툴리눔 신경독의 신규 용도 | |
| JPWO2019162376A5 (https=) | ||
| CN112739320A (zh) | 肉毒杆菌神经毒素血清型e的治疗和美容用途 | |
| RU2020131317A (ru) | Биогибрид ботулинического нейротоксина | |
| RU2826569C2 (ru) | Новые способы применения ботулинического нейротоксина для лечения тремора | |
| RU2019108257A (ru) | Сконструированный ботулинический нейротоксин | |
| RU2778481C2 (ru) | Улучшенное применение ботулинического нейротоксина в лечении сиалореи | |
| NZ747619B2 (en) | Chimeric neurotoxins |